Home › Atopic Dermatitis (Eczema) › Florida › Tampa
Atopic Dermatitis (Eczema) clinical trials in Tampa, FL
6 studies for Atopic Dermatitis (Eczema) are looking for participants at sites in and around Tampa (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares
RecruitingObservational study
- True Blue Clinical Research, Tampa
A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
RecruitingPhase 3
- Leo Pharma Investigational site, Tampa
A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema
RecruitingPhase 3
- Advanced Clinical Research Institute, Tampa
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
RecruitingPhase 2
- NMC Research LLC, Tampa
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
RecruitingPhase 2
- Inmagene Site 4, Tampa
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
RecruitingObservational study
- Galderma Investigational Site 7054, Tampa
Atopic Dermatitis (Eczema) trials in other cities
- Los Angeles, CA12 studies
- New York City, NY12 studies
- Miami, FL11 studies
- Birmingham, AL10 studies
- Washington, DC10 studies
- San Antonio, TX9 studies
- Huntington Beach, CA9 studies
- San Diego, CA9 studies
- Dallas, TX8 studies
- Little Rock, AR7 studies
- Troy, MI7 studies
- Indianapolis, IN7 studies
Other studies in Tampa
- Non-Small Cell Lung Cancer53 studies
- Breast Cancer40 studies
- Cancer (all types)38 studies
- Colorectal Cancer36 studies
- Lung Cancer31 studies
- Metastatic Cancer30 studies
- Acute Myeloid Leukemia30 studies
- Pancreatic Cancer26 studies
- Melanoma21 studies
- Ovarian Cancer20 studies
- Alzheimer's Disease20 studies
- Myelodysplastic Syndromes20 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.